---
title: "Akero Therapeutics' Chief Scientific Officer Sells Shares"
date: "2025-02-08 07:10:00"
summary: "Reporter NameRolph TimothyRelationshipChief Scientific OfficerTypeSellAmount$1,059,629SEC FilingForm 4Rolph Timothy, Chief Scientific Officer of Akero Therapeutics, sold a total of 18,750 shares of common stock on February 5, 2025, under a Rule 10b5-1 trading plan. The sales were conducted at weighted average prices of $56.325 and $56.924, with the total sale amounting..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

| Reporter Name | Rolph Timothy |
| --- | --- |
| Relationship | Chief Scientific Officer |
| Type | Sell |
| Amount | $1,059,629 |
| SEC Filing | [Form 4](https://www.sec.gov/Archives/edgar/data/1779479/000095017025016493/xslF345X05/ownership.xml) |

Rolph Timothy, Chief Scientific Officer of Akero Therapeutics, sold a total of 18,750 shares of common stock on February 5, 2025, under a Rule 10b5-1 trading plan. The sales were conducted at weighted average prices of $56.325 and $56.924, with the total sale amounting to $1,059,629. Following these transactions, Timothy directly owns 170,237 shares of Akero Therapeutics.

SEC Filing: [Akero Therapeutics, Inc. [ AKRO ] - Form 4 - Feb. 07, 2025](https://www.sec.gov/Archives/edgar/data/1779479/000095017025016493/xslF345X05/ownership.xml)

[TradingView](https://www.tradingview.com/news/tradingview:14f737a84b441:0-akero-therapeutics-chief-scientific-officer-sells-shares/)
